Programmed cell death 1 (PD‐1)/PD‐ligand 1(PD‐L1) inhibitors‐related pneumonitis in patients with advanced non–small cell lung cancer

Immune‐related pneumonitis is an uncommon but potentially fatal immune‐related adverse event in advanced non–small cell lung cancer (NSCLC) patients during treatment with anti‐programmed cell death 1 (PD‐1) and programmed cell death‐ligand 1 (PD‐L1). Underlying emphysema, interstitial lung disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yuxin, Shao, Chi, Li, Shan, Xu, Yan, Xu, Kai, Zhang, Ying, Huang, Hui, Wang, Mengzhao, Xu, Zuojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754394/
https://www.ncbi.nlm.nih.gov/pubmed/32757454
http://dx.doi.org/10.1111/ajco.13380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754394/
https://www.ncbi.nlm.nih.gov/pubmed/32757454
http://dx.doi.org/10.1111/ajco.13380

Ejemplares similares